about
Disruption of mannose activation in Leishmania mexicana: GDP-mannose pyrophosphorylase is required for virulence, but not for viability.Depletion of UDP-Glucose and UDP-Galactose Using a Degron System Leads to Growth Cessation of Leishmania majorPartial structure of glutamic acid and alanine-rich protein, a major surface glycoprotein of the insect stages of Trypanosoma congolense.Structural characterization of NETNES, a novel glycoconjugate in Trypanosoma cruzi epimastigotes.The promastigote surface antigen gene family of the Leishmania parasite: differential evolution by positive selection and recombination.Leishmania major glycosylation mutants require phosphoglycans (lpg2-) but not lipophosphoglycan (lpg1-) for survival in permissive sand fly vectors.Transmission of cutaneous leishmaniasis by sand flies is enhanced by regurgitation of fPPG.N-linked glycosylation in Archaea: a structural, functional, and genetic analysis.Synthetic neoglycoconjugates of cell-surface phosphoglycans of Leishmania as potential anti-parasite carbohydrate vaccinesProteophosphoglycan confers resistance of Leishmania major to midgut digestive enzymes induced by blood feeding in vector sand flies.Secretory pathway of trypanosomatid parasites.Deletion of UDP-glucose pyrophosphorylase reveals a UDP-glucose independent UDP-galactose salvage pathway in Leishmania majorGlycosylation defects and virulence phenotypes of Leishmania mexicana phosphomannomutase and dolicholphosphate-mannose synthase gene deletion mutants.Differential microbicidal effects of human histone proteins H2A and H2B on Leishmania promastigotes and amastigotes.Leishmania lipophosphoglycan: how to establish structure-activity relationships for this highly complex and multifunctional glycoconjugate?LdFlabarin, a new BAR domain membrane protein of Leishmania flagellum.Pathogen-derived oligosaccharides improve innate immune response to intracellular parasite infectionSugar nucleotide pools of Trypanosoma brucei, Trypanosoma cruzi, and Leishmania major.Comparisons of mutants lacking the Golgi UDP-galactose or GDP-mannose transporters establish that phosphoglycans are important for promastigote but not amastigote virulence in Leishmania majorThe role of leishmania proteophosphoglycans in sand fly transmission and infection of the Mammalian host.Surface antigens and potential virulence factors from parasites detected by comparative genomics of perfect amino acid repeats.Structure of a complex phosphoglycan epitope from gp72 of Trypanosoma cruzi.Comparative genomics: from genotype to disease phenotype in the leishmaniases.Functional paradox in host-pathogen interaction dictates the fate of parasites.Transgenic Leishmania and the immune response to infectionLeishmania donovani lacking the Golgi GDP-Man transporter LPG2 exhibit attenuated virulence in mammalian hostsDrug delivery strategies for therapy of visceral leishmaniasis.Glycobiology of the Leishmania parasite and emerging targets for antileishmanial drug discovery.Proteinases as virulence factors in Leishmania spp. infection in mammals.Leishmania cell wall as a potent target for antiparasitic drugs. A focus on the glycoconjugates.The role of phosphoglycans in the susceptibility of Leishmania mexicana to the temporin family of anti-microbial peptides.An Alternative Strategy for Trypanosome Survival in the Mammalian Bloodstream Revealed through Genome and Transcriptome Analysis of the Ubiquitous Bovine Parasite Trypanosoma (Megatrypanum) theileri.Proteophosphoglycan is differentially expressed in sodium stibogluconate-sensitive and resistant Indian clinical isolates of Leishmania donovani.Two functionally divergent UDP-Gal nucleotide sugar transporters participate in phosphoglycan synthesis in Leishmania major.Abortive infection of Lutzomyia longipalpis insect vectors by aflagellated LdARL-3A-Q70L overexpressing Leishmania amazonensis parasites.Cloning of Trypanosoma brucei and Leishmania major genes encoding the GlcNAc-phosphatidylinositol de-N-acetylase of glycosylphosphatidylinositol biosynthesis that is essential to the African sleeping sickness parasite.Differential endocytic functions of Trypanosoma brucei Rab5 isoforms reveal a glycosylphosphatidylinositol-specific endosomal pathway.Virus-like Particle Display of the α-Gal Carbohydrate for Vaccination against Leishmania Infection.Isolation of Toxoplasma gondii development mutants identifies a potential proteophosphogylcan that enhances cyst wall formation.The role of phosphomannose isomerase in Leishmania mexicana glycoconjugate synthesis and virulence.
P2860
Q28343727-DA32B6C2-6D17-456F-B98D-6BABCF79262BQ28550611-94883C7F-AA27-4FDF-A154-ED91A7F2DD25Q30860318-BF2E435C-9AED-4683-B845-B2329E4F8BC1Q33210849-C0EEC81D-2F89-4949-95FF-593E9093BFEEQ33379257-9FF08569-98FF-4259-8098-895D6384D348Q33525007-D4378A6F-644F-4D43-B971-69A0DE5F1063Q33714994-745DE1F1-C4DD-4138-A4F4-CCD37CDAF1EFQ33743511-8666052E-97BD-4669-9242-598D04C20C93Q33870163-99EAFA44-22C8-482E-9AA9-8659B2271417Q33938758-EEB3FDD1-C4D3-43FD-A1D7-0E5B30E140E9Q33969495-0FBA580B-25BD-488E-90E4-3D101DCA13F2Q33979086-6473CC02-28CD-42AF-B337-5338BB5BAD2AQ34012884-407D2DFC-D073-404C-B304-8713E82A70CDQ34739899-1568593D-67EE-4CC7-A321-44B5309224B8Q34992273-7AB94311-710B-42ED-8530-E22EE350FA7FQ35006337-59C9D6FC-9A54-4074-A4C8-34363404FA3AQ35167881-F392ABD5-2689-4ED6-9DEB-848D35ACBEDAQ35947133-9D535E8D-1990-40C8-BB27-CB34433282EDQ35947298-016B0CB5-48B5-4843-B47A-32921230FE24Q36063617-6BD5E9E3-C706-4647-B055-03E908731040Q36478612-F5071363-1EB1-44EF-B3E4-E6821DE3F835Q36779501-DFF9EE0D-BAE8-4F1E-901C-EE5148FFA381Q36889371-33CE5093-06B0-46AC-B87E-165D88B9AF47Q36903844-083E7A5A-8D93-459D-8F60-21FA5989DBEAQ37081691-FDFA78BB-E8C2-4F07-9EC2-51B6DFF74C15Q37288178-09677420-D7C9-41A5-A132-DA3714CF9D16Q37702257-21938A47-FB4C-4207-92D9-C1A5007D36F9Q37763950-7185EFDA-F764-492E-A9EC-A9B9AAD418AEQ38032623-FE39B5B6-1A90-4093-8F87-D0C7B97D8599Q38541158-4A720BCD-A9FE-481A-B28D-3E52A512EC5BQ38982884-D0BB0A13-D8BE-4039-8464-902B32AEED98Q40048486-D7387675-C88D-4E97-A1EB-08F47837C721Q40158689-2AC49C27-D0AA-4AAB-B7BD-EEB7DB8744EBQ40161633-67D63199-9E02-46A0-941D-8F17184AEA1BQ40562901-6C253FD8-E831-4DB5-9C91-CCF21B51EA5BQ40699796-A563A2FA-0649-4226-A8A9-0B92E93E4CF0Q40761743-26C648D3-52EB-4950-9D38-34A2189F9821Q41894108-4E8444D4-48C8-452C-A1FB-673C67B124CEQ42029678-CA06D4EC-5995-4034-9C02-DF9B38BAEFA9Q43510112-B8910030-BB6E-4A47-827A-AE336F275F6C
P2860
description
2000 nî lūn-bûn
@nan
2000 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
name
Proteophosphoglycans of Leishmania.
@ast
Proteophosphoglycans of Leishmania.
@en
Proteophosphoglycans of Leishmania.
@nl
type
label
Proteophosphoglycans of Leishmania.
@ast
Proteophosphoglycans of Leishmania.
@en
Proteophosphoglycans of Leishmania.
@nl
prefLabel
Proteophosphoglycans of Leishmania.
@ast
Proteophosphoglycans of Leishmania.
@en
Proteophosphoglycans of Leishmania.
@nl
P1476
Proteophosphoglycans of Leishmania.
@en
P2093
P304
P356
10.1016/S0169-4758(00)01791-9
P577
2000-11-01T00:00:00Z